Pages that link to "Q64912866"
Jump to navigation
Jump to search
The following pages link to Activating L265P mutations of the MYD88 gene are common in primary central nervous system lymphoma. (Q64912866):
Displaying 50 items.
- Beyond high-dose methotrexate and brain radiotherapy: novel targets and agents for primary CNS lymphoma (Q27013785) (← links)
- Genome-Wide Analysis Uncovers Novel Recurrent Alterations in Primary Central Nervous System Lymphomas. (Q30299913) (← links)
- Advances in Primary Central Nervous System Lymphoma (Q31007237) (← links)
- Clinicopathologic significance of MYD88 L265P mutation in diffuse large B-cell lymphoma: a meta-analysis (Q33687549) (← links)
- Progress in central nervous system lymphomas. (Q33934406) (← links)
- Mutational analysis of primary central nervous system lymphoma (Q34104139) (← links)
- JAKs and STATs in immunity, immunodeficiency, and cancer (Q34321767) (← links)
- Emerging therapeutic paradigms to target the dysregulated Janus kinase/signal transducer and activator of transcription pathway in hematological malignancies (Q35132241) (← links)
- Gene Mutation Profiles in Primary Diffuse Large B Cell Lymphoma of Central Nervous System: Next Generation Sequencing Analyses (Q36939219) (← links)
- New approaches in primary central nervous system lymphoma (Q37088471) (← links)
- How I treat CNS lymphomas (Q37215118) (← links)
- Cerebrospinal Fluid IL-10 and IL-10/IL-6 as Accurate Diagnostic Biomarkers for Primary Central Nervous System Large B-cell Lymphoma (Q37479559) (← links)
- Activation of TAK1 by MYD88 L265P drives malignant B-cell Growth in non-Hodgkin lymphoma. (Q37621361) (← links)
- Toll-like Receptors in Chronic Lymphocytic Leukemia (Q38042942) (← links)
- Targeting pathological B cell receptor signalling in lymphoid malignancies (Q38085501) (← links)
- Waldenström macroglobulinemia: clinical and immunological aspects, natural history, cell of origin, and emerging mouse models (Q38150849) (← links)
- Pathology of B-cell lymphomas: diagnosis and biomarker discovery (Q38345563) (← links)
- Ibrutinib Unmasks Critical Role of Bruton Tyrosine Kinase in Primary CNS Lymphoma. (Q38723290) (← links)
- The Challenge of Primary Central Nervous System Lymphoma. (Q39020652) (← links)
- Primary central nervous system lymphoma: essential points in diagnosis and management (Q39185721) (← links)
- MYD88 L265P in Waldenström macroglobulinemia, immunoglobulin M monoclonal gammopathy, and other B-cell lymphoproliferative disorders using conventional and quantitative allele-specific polymerase chain reaction (Q41149988) (← links)
- Non-invasive detection of somatic mutations using next-generation sequencing in primary central nervous system lymphoma. (Q41471491) (← links)
- High prevalence of oncogenic MYD88 and CD79B mutations in diffuse large B-cell lymphomas presenting at immune-privileged sites (Q41960712) (← links)
- Diffuse large B cell lymphomas relapsing in the CNS lack oncogenic MYD88 and CD79B mutations (Q43130086) (← links)
- Differential diagnosis of lymphoid infiltrates in the central nervous system: experience of the Network Lymphomas and Lymphomatoid Lesions in the Nervous System (Q44757897) (← links)
- High prevalence of oncogenic MYD88 and CD79B mutations in primary testicular diffuse large B-cell lymphoma (Q45183858) (← links)
- Bing-Neel Syndrome: Illustrative Cases and Comprehensive Review of the Literature. (Q47144661) (← links)
- The use of droplet digital PCR in liquid biopsies: A highly sensitive technique for MYD88 p.(L265P) detection in cerebrospinal fluid (Q47930491) (← links)
- Mapping the human T cell repertoire to recurrent driver mutations in MYD88 and EZH2 in lymphoma (Q47947510) (← links)
- Cytomorphology and flow cytometry of brain biopsy rinse fluid enables faster and multidisciplinary diagnosis of large B-cell lymphoma of the central nervous system. (Q48133464) (← links)
- Role of Bruton's tyrosine kinase in B cells and malignancies (Q49888075) (← links)
- Identification of novel recurrent ETV6-IGH fusions in primary central nervous system lymphoma. (Q50061613) (← links)
- [Primary vitreoretinal lymphoma]. (Q52626341) (← links)
- The mutational pattern of primary lymphoma of the central nervous system determined by whole-exome sequencing. (Q53022781) (← links)
- [The clinical features of patients with lymphoplasmacytic diseases harboring MyD88 L265P mutation]. (Q53574665) (← links)
- MYD88 L265P is a marker highly characteristic of, but not restricted to, Waldenström's macroglobulinemia. (Q54270566) (← links)
- Target amplicon exome-sequencing identifies promising diagnosis and prognostic markers involved in RTK-RAS and PI3K-AKT signaling as central oncopathways in primary central nervous system lymphoma. (Q55228721) (← links)
- Primary extra-nodal diffuse large B-cell lymphoma: A prognostic analysis of 141 patients. (Q55712161) (← links)
- The Diagnosis and Treatment of Primary CNS Lymphoma (Q56967801) (← links)
- Array-based profiling of the lymphoma cell DNA methylome does not unequivocally distinguish primary lymphomas of the central nervous system from non-CNS diffuse large B-cell lymphomas (Q57036578) (← links)
- Primary CNS lymphoma (Q59399605) (← links)
- Design of a Novel and Selective IRAK4 Inhibitor Using Topological Water Network Analysis and Molecular Modeling Approaches (Q60928903) (← links)
- L265P mutation and loss are early mutational events in primary central nervous system diffuse large B-cell lymphomas (Q61799197) (← links)
- Primary Central Nervous System Lymphoma: Molecular Pathogenesis and Advances in Treatment (Q64236549) (← links)
- Differential expression of Toll-like receptor (TLR) and B cell receptor (BCR) signaling molecules in primary diffuse large B-cell lymphoma of the central nervous system (Q85952940) (← links)
- Prevalence And Clinical Significance Of Oncogenic CD79B And MYD88 Mutations In Primary Testicular Diffuse Large B-Cell Lymphoma: A Retrospective Study In China (Q89735564) (← links)
- Primary vitreoretinal lymphomas display a remarkably restricted immunoglobulin gene repertoire (Q91728778) (← links)
- Genetic alterations and their clinical implications in DLBCL (Q92283033) (← links)
- Comprehensive approach to diagnosis and treatment of newly diagnosed primary CNS lymphoma (Q93002931) (← links)
- Introduction of novel agents in the treatment of primary CNS lymphoma (Q93036115) (← links)